Induction of phase II enzymes and inhibition of cytochrome P450 isozymes by chitosanoligosaccharides

Journal of Microbiology and Biotechnology

Volumn 15, Issue 1, 2005, Pages 183-187

  Shon, Yun Hee ^a   Nam, Kyung Soo ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Chitosanoligosaccharide; Cytochrome P450; Glutathione S transferase; Quinone reductase

Indexed keywords

ANTINEOPLASTIC AGENT; CHITOSANOLIGOSACCHARIDE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2B1; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; IN VITRO STUDY; INCUBATION TIME; LIVER MICROSOME; MALE; NONHUMAN; RAT;

EID: 15044354882     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bandaru, S. R., V. R. Chinthalapally, R. Abraham, and K. Gary. 1993. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res. 53: 3493-3498.
2. Bogaards, J. J. P., H. Verhagen, M. I. WilIems, G. van Poppel, and P. J. van Bladeren. 1994. Consumption of Brussels sprouts results in elevated α-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 15: 1073-1075.
3. Burke, M. D., S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta, and R. T. Mayer. 1985. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34: 3337-3345.
4. Dicker, E., Y. McHugh, and A. I. Cederbaum. 1990. Increased oxidation of p-nitrophenol and aniline by intact hepatocytes isolated from pyrazole-treated rats. Biochim. Biophys. Acta 1035: 249-256.
5. Guengerich, F. P. 1988. Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48: 2946-2954.
6. Guo, Z., T. J. Smith, E. Wang, K. I. Eklind, F. L. Chung, and C. S. Yang. 1993. Structure activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolising enzymes in rats and mice. Carcinogenesis 14: 1167-1173.
7. Habig, W. H., M. J. Pabst, and W. B. Jakoby. 1974. Glutathione S-transferases: The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7139.
8. Hong, I. P., K. J. Hong, Y. L. Shin, and G. C. Shin. 2003. Cloning and characterization of a bifunctional cellulase-chitosanase gene from Bacillus licheniformis NBL420. J. Microbiol. Biotechnol. 13: 35-42.
9. Hong, W. K. and M. B. Sporn. 1997. Recent advances in chemoprevention of cancer. Science 278: 1073-1077.
10. Izume, M. and A. Ohtakara. 1987. Preparation of D-glucosamine oligosaccharides by the enzymatic hydrolysis of chitosan. Agric. Biol. Chem. 51: 1189-1191.
11. Jo, Y. Y., K. J. Jo, Y. L. Jin, W. J. Jung, J. H. Kuk, K. Y. Kim, T. H. Kim, and R. D. Park. 2003. Characterization of endochitosanases-producing Bacillus cereus P16. J. Microbiol. Biotechnol. 13: 960-968.
12. Kato, H., T. Taguchi, H. Okuda, M. Kondo, and M. Takara. 1994. Antihypertensive effect of chitosan in rats and humans. J. Tradit. Chin. Med. 11: 198-205.
13. Kensler, T. W., P. A. Egner, P. M. Dolan, J. D. Groopman, and B. D. Roebuck. 1987. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-thones. Cancer Res. 47: 4271-4277.
14. Kent, U. M., D. E. Mills, R. V. Rajnarayanan, W. L. Alworth, and P. F. Hollenberg. 2002. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: Characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. J. Pharmacol. Exp. Ther 300: 549-558.
15. Lee, J. E. and S. Safe. 2001. Involvement of a posttranscriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells. Biochem. Pharmacol. 62: 1113-1124.
16. Loizou, G. D. and J. Cocker. 2001. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: A phenotyping study using chlorzoxazone. Hum. Exp. Toxicol. 20: 321-327.
17. Marcinkicwicz, J., A. Polewska, and J. Knapczyk. 1991. Immunoadjuvant properties of chitosan. Arch. Immunol. Ther. Exp. (Warsz) 39: 127-132.
18. Nam, K. S., Y. R. Choi, and Y. H. Shon. 2001. Evaluation of the antimutagenic potential of chitosan oligosaccharide: Rec, Ames and Umu assays. Biotechnol. Lett. 23: 971-975.
19. Ormrod, D. J., C. C. Holmes, and T. E. Miller. 1998. Dietary chitosan inhibits hypercholesterolemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138: 329-334.
20. Park, P. J., H. K. Lee, and S. K. Kim. 2004. Preparation of hetero-chitooligosaccharides and their antimicrobial activity on Vibrio parahaemolyticus. J. Microbiol. Biotechnol. 14: 41-47.
21. Prochaska, H. J. and C. L. Fernandes. 1993. Elevation of serum phase II enzymes by anticarcinogenic enzyme inducers: Markers for a chemoprotected state? Carcinogenesis 14: 2441-2445.
22. Schweikl, H., J. A. Taylor, S. Kitareewan, P. Linko, D. Nagorney, and J. A. Goldstein. 1993. Expression of CYP 1A1 and CYP 1A2 genes in human liver. Pharmacogenetics 3: 239-249.
23. Shon, Y. H., I. K. Park, I. S. Moon, H. W. Chang, I. K. Park, and K. S. Nam. 2002. Effect of chitosan oligosaccharide on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in mice. Biol. Pharm. Bull. 25: 1161-1164.
24. Shon, Y. H. and K. S. Nam. 2003. Inhibition of polyamine biosynthesis of Acanthamoeba castellanii and 12-O tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by chitosanoligosaccharide. Biotechnol. Lett. 25: 701-704.
25. Shon, Y. H., K. S. Nam, and M. K. Kim. 2004. Cancer chemopreventive potential of Scenedesmus spp. cultured in medium containing bioreacted swine urine. J. Microbiol. Biotechnol. 14: 158-161.
26. Talalay, P., J. W. Fahey, W. D. Holtzclaw, T. Prestera, and Y. Zhang. 1995. Chemoprotection against cancer by phase II enzyme induction. Toxicol. Lett. (Amst.) 82: 173-179.
27. Tsukada, K., T. Matsumoto, K. Aizawa, A. Tokoro, R. Naruse, S. Suzuki, and M. Suzuki. 1990. Antimetastatic and growth-inhibitory effects of N-acetylchitohexaose in mice bearing Lewis lung carcinoma. Jpn. J. Cancer Res. 81: 259-265.
28. Yang, C. S., T. J. Smith, and J. Y. Hong. 1994. Cytochrome P450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: Opportunities and limitations. Cancer Res. 54(Suppl.): 1982s-1986s.
29. Zhang, Y., T. W. Kensler, C. G. Cho, G. H. Posner, and P. Talalay. 1994. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA 91: 3147-3150.